Atsushi Kumanogoh Selected Research

Semaphorins (Semaphorin)

1/2022	Axon guidance molecules in immunometabolic diseases.
11/2021	Neural guidance factors as hubs of immunometabolic cross-talk.
10/2020	Olig2-Induced Semaphorin Expression Drives Corticospinal Axon Retraction After Spinal Cord Injury.
12/2018	Semaphorin 7A promotes EGFR-TKI resistance in EGFR mutant lung adenocarcinoma cells.
1/2018	The role of semaphorins in immune responses and autoimmune rheumatic diseases.
11/2016	The role of Sema4A in angiogenesis, immune responses, carcinogenesis, and retinal systems.
12/2015	[Semaphorins as treatment targets for cartilage and bone damage caused by rheumatoid arthritis].
5/2014	Plexin-A1 is required for Toll-like receptor-mediated microglial activation in the development of lipopolysaccharide-induced encephalopathy.
3/2013	Semaphorins in bone development, homeostasis, and disease.
1/2013	A point mutation in Semaphorin 4A associates with defective endosomal sorting and causes retinal degeneration.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Atsushi Kumanogoh Research Topics

Disease

60	Neoplasms (Cancer) 07/2022 - 01/2007
21	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 06/2012
21	Rheumatoid Arthritis 01/2022 - 01/2012
17	Inflammation (Inflammations) 01/2022 - 04/2007
10	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2018 - 08/2002
9	Lung Neoplasms (Lung Cancer) 07/2022 - 01/2013
9	COVID-19 06/2022 - 01/2021
9	Fibrosis (Cirrhosis) 11/2020 - 07/2012
8	Neoplasm Metastasis (Metastasis) 01/2022 - 07/2008
8	Multiple Sclerosis 08/2021 - 08/2008
7	Arthritis (Polyarthritis) 03/2022 - 01/2012
6	Disease Progression 03/2022 - 01/2014
6	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2017 - 04/2012
6	Leukemia 01/2016 - 12/2012
5	Interstitial Lung Diseases (Interstitial Lung Disease) 03/2022 - 10/2014
5	Neuromyelitis Optica (Devic's Disease) 01/2022 - 03/2009
5	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 12/2011
5	Infections 01/2022 - 01/2020
5	Emphysema 01/2022 - 10/2013
4	Osteoporosis 10/2022 - 03/2013
4	Pneumonia (Pneumonitis) 03/2022 - 01/2013
4	Adenocarcinoma of Lung 01/2022 - 01/2012
4	Psoriatic Arthritis 05/2021 - 01/2012
4	Fever (Fevers) 05/2021 - 01/2013
4	Chronic Obstructive Pulmonary Disease (COPD) 01/2021 - 01/2012
4	Hypoxia (Hypoxemia) 01/2021 - 05/2015
4	Bone Resorption 01/2021 - 01/2011
4	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 01/2020 - 08/2017
4	Vasculitis (Vasculitides) 01/2020 - 08/2017
4	Hypersensitivity (Allergy) 01/2018 - 07/2009
4	Carcinogenesis 11/2016 - 06/2006
3	Systemic Lupus Erythematosus (Libman-Sacks Disease) 03/2022 - 01/2018
3	Systemic Scleroderma (Systemic Sclerosis) 02/2022 - 01/2015
3	Hypertension (High Blood Pressure) 01/2022 - 01/2013
3	Hematologic Neoplasms (Hematological Malignancy) 01/2022 - 05/2011
3	Idiopathic Interstitial Pneumonias 01/2022 - 10/2014
3	Necrosis 01/2022 - 03/2009
3	Idiopathic Pulmonary Fibrosis 01/2022 - 01/2014
3	Respiratory Insufficiency (Respiratory Failure) 07/2021 - 11/2014
3	Lung Diseases (Lung Disease) 01/2021 - 01/2013
3	Pulmonary Alveolar Proteinosis 01/2021 - 11/2014
3	Pulmonary Hypertension 01/2021 - 05/2015
3	Colitis 01/2021 - 02/2012
3	Adenocarcinoma 12/2020 - 01/2012
3	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2020 - 07/2012
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2017 - 10/2013

Drug/Important Bio-Agent (IBA)

21	Proteins (Proteins, Gene)FDA Link 10/2022 - 07/2010
19	Peptides (Polypeptides)IBA 01/2022 - 08/2002
17	Semaphorins (Semaphorin)IBA 01/2022 - 06/2006
16	AntigensIBA 01/2022 - 04/2007
14	Biomarkers (Surrogate Marker)IBA 06/2022 - 12/2016
12	Pharmaceutical PreparationsIBA 01/2022 - 01/2013
12	Immune Checkpoint InhibitorsIBA 01/2022 - 08/2018
12	CD100 antigenIBA 01/2020 - 01/2007
10	AutoantibodiesIBA 02/2022 - 03/2009
10	Biological ProductsIBA 07/2021 - 11/2004
9	VaccinesIBA 03/2022 - 02/2014
9	CytokinesIBA 01/2017 - 04/2007
8	Protein Subunit VaccinesIBA 01/2022 - 07/2015
7	Immunoglobulin G (IgG)IBA 02/2022 - 03/2009
7	Monoclonal AntibodiesIBA 01/2022 - 10/2002
7	AntibodiesIBA 01/2022 - 04/2016
7	Antirheumatic Agents (DMARD)IBA 07/2021 - 01/2018
6	EpitopesIBA 01/2022 - 12/2012
6	TetraspaninsIBA 01/2020 - 07/2012
6	WT1 ProteinsIBA 11/2018 - 03/2012
5	Messenger RNA (mRNA)IBA 03/2022 - 07/2015
5	InterferonsIBA 03/2022 - 12/2012
5	tocilizumab (atlizumab)FDA Link 09/2020 - 01/2012
5	Interleukin-17 (Interleukin 17)IBA 03/2020 - 05/2015
5	Interleukin-6 (Interleukin 6)IBA 01/2017 - 11/2004
4	Phosphotransferases (Kinase)IBA 10/2022 - 07/2013
4	Cancer VaccinesIBA 01/2022 - 02/2014
4	NivolumabIBA 01/2022 - 10/2018
4	Therapeutic UsesIBA 01/2022 - 01/2017
4	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2013
4	LigandsIBA 01/2021 - 01/2019
4	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2020 - 11/2014
4	Tyrosine Kinase InhibitorsIBA 01/2020 - 02/2017
4	Myelin-Oligodendrocyte GlycoproteinIBA 04/2011 - 08/2002
3	Adrenal Cortex Hormones (Corticosteroids)IBA 02/2022 - 01/2020
3	HLA-A*24:02 antigenIBA 01/2022 - 12/2012
3	Janus Kinase InhibitorsIBA 01/2022 - 01/2020
3	SteroidsIBA 01/2022 - 01/2017
3	pembrolizumabIBA 01/2022 - 01/2019
3	ProteomeIBA 01/2022 - 12/2017
3	Granzymes (Granzyme)IBA 01/2022 - 04/2013
3	Dextran SulfateIBA 01/2021 - 01/2017
3	Pancreatic Elastase (Elastase)IBA 01/2021 - 10/2013
3	GlucocorticoidsIBA 01/2021 - 01/2017
3	ErbB Receptors (EGF Receptor)IBA 01/2020 - 09/2013
3	ChemokinesIBA 01/2020 - 06/2012
3	InterleukinsIBA 01/2020 - 01/2012
3	Bleomycin (Blenoxane)FDA LinkGeneric 01/2020 - 07/2012
3	Gemcitabine FDA Link 01/2018 - 01/2013
3	IntegrinsIBA 12/2017 - 04/2007
3	Irinotecan (Camptosar)FDA LinkGeneric 01/2017 - 04/2012

Therapy/Procedure

27	Therapeutics 03/2022 - 05/2010
26	Immunotherapy 07/2022 - 05/2011
12	Drug Therapy (Chemotherapy) 01/2022 - 01/2012